CD14 PE

CD14 PE
Regulatory status
CE IVD
Format
PE
Reactivity
Non-human primates, Human
Application
FC (QC tested)
Excitation laser
blue (488 nm)
Variant
100 tests
ED7015
In stock
0.00 USD
Variant
0.1 mg
11-261-C100
In stock
0.00 USD
Product details
References
Application
FC (QC tested)
Reactivity
Non-human primates, Human
Description
The reagent CD14 PE permits identification and enumeration of cell populations expressing human CD14 antigen in whole blood using flow cytometry.
Contents
The reagent contains mouse monoclonal antibody against human CD14 antigen (clone MEM-15) which was purified by affinity chromatography and labeled with R-Phycoerythrin (PE). The labeled antibody is diluted at optimum concentration in stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide. The content of a vial (2 ml) is sufficient for 100 tests.
Preparation
The purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography.
Formulation
Stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide
Storage and handling
Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light. Do not use after expiration date stamped on vial label.
Exbio licence note
The product is intended for In Vitro Diagnostic Use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Product specific references:

Asai Y et al. (2007) Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation. J Immunol. 179: 7674-83
Lodrup Carlsen KC and Granum B (2007) Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr Allergy Asthma Rep. 7: 436-43
Fernández-Real JM et al. (2003) CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab. 88: 1780-4
Juan TS et al. (1995) Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biol Chem. 270: 17237-42
Bazil V et al. (1986) Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol. 16: 1583-9
Leukocyte Typing VI., Kishimoto T. et al. (Eds.), Garland Publishing Inc. (1997).
Leukocyte Typing V., Schlossman S. et al. (Eds.), Oxford University Press (1995).
Leukocyte Typing IV., Knapp W. et al. (Eds.), Oxford University Press (1989).
Leukocyte Typing III., McMichael A. J. et al (Eds.), Oxford University Press (1987).
Variant
100 tests
ED7015
In stock
0.00 USD
Variant
0.1 mg
11-261-C100
In stock
0.00 USD